FENC
FENNEC PHARMACEUTICALS INC.
FENNEC PHARMACEUTICALS INC. (FENC) has 14 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
The most active filer is Insider Raykov Rosty with 3 filings. Insiders have net sold $322K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Jeffrey S. Hackman
- Employees:35
- HQ:Research Triangle Park, NC, US
- IPO:2017-09-15
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$322K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$358.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Former Director | Sale | 9,599 | $100K | Jul 2 | SEC ↗ | |
| Director | Sale | 9,747 | $94K | Jun 2 | SEC ↗ | |
RALLIS CHRIS AFirst filing | Director | Sale | 8,346 | $59K | May 12 | SEC ↗ |
Raykov RostyFirst filing | Director | Sale | 10,781 | $70K | May 1 | SEC ↗ |
Related companies
FENNEC PHARMACEUTICALS INC. is in the Healthcare sector.